• Flex Pharma Stops Phase 2 Trial of FLX-787 to Ease Muscle Cramps in ALS Patients
  • Prediction Model May Help Personalize Survival Prognosis in ALS Patients, Researchers Say
  • Higher Risk of Pressure Sores in ALS Patients; Women, Young More Vulnerable, Study Finds
  • Changes in Brain Structure, Blood Flow Linked to Varying Cognitive Deficits in ALS
  • Phase 1/2a Trial Recruiting ALS Patients to Test AstroRx, Potential New Stem Cell Therapy
  • Specific RNA Alterations Key in ALS, Study Suggests
  • Infusing Treg Immune Cells Has Potential to Slow ALS, Small Study Suggests
  • Canada Trails US in Patient Access to Rare Disease Therapies, CORD President Says
  • The Placebo Effect of Fighting ALS
  • Higher Genetic Risk for ALS Linked to Poorer Verbal, Numerical Skills in Adults in UK Study
  • How to Build Your Own ALS Stress Toolkit
  • Insights from New System May Help Improve Speech Impairment in ALS, Other Disorders, Study Reports